Narkar A A, Shah D H, Yadav J, Swaroop D, Mulherkar R
Radiation Medicine Center, B.A.R.C., Parel, Bombay, India.
Hybridoma. 1992 Dec;11(6):803-13. doi: 10.1089/hyb.1992.11.803.
We have earlier reported production and characterization of monoclonal antibodies (MAbs) to human thyroglobulin (h-tg). In the present study H10 I MAb was evaluated for its immunoreactivity towards different forms of tg and various human thyroid tumours. The specificity of H10 I MAb was validated by the absence of cross reaction with tri-iodothyronine (T3) Thyroxine (T4) and human gamma globulins. Sodium-dodicyl-sulphate polyacrylamide gel electrophoresed (SDS-PAGE) immunoblot of h-tg on the nitrocellulose membrane revealed multiple immunoreactive bands on reaction with polyclonal antibody (PAb) in comparison with total lack of reactivity with H10 I MAb. The absence of immunoreactivity of H10 I MAb was demonstrated with SDS treated, Dithiothreitol (DT) treated and heat denatured tg using dot immunobinding technique. However, the H10 I MAb was able to react with tg treated with unfolding agents such as urea and guanidine hydrochloride. All the treated forms of tg were equally recognized by PAb. The immunoreactivity of the oxidized/reduced tg towards H10 I MAb was markedly reduced (60.0%) as compared to that obtained with native tg. It appears that H10 I MAb is directed towards conformational epitope involving sulphydryl bonds. Immunohistochemically, a comparable immunoreactivity between PAb and MAb was observed with normal thyroid tissues, follicular thyroid tissues, Hurthle cell carcinoma tissues and poorly differentiated thyroid tumor tissues using immunoperoxidase staining. The sections from papillary carcinoma tissue (thyroid as well as metastatic lymph node) exhibited intense immunoreactivity with PAb. Thyroglobulin present on these sections was not recognized by H10 I MAb. Nonetheless, H10 I MAb was able to detect tg in follicular differentiation wherever present. The absence of immunoreactivity of H10 I MAb in papillary carcinoma strongly suggests that this neoplasm produces tg which is antigenically different from the protein present in the normal tissue. The reactivity of H10 I MAb with metastatic lymph node of an unknown primary origin suggests its usefulness in the identification of prevalent metastasis of differentiated thyroid carcinoma other than papillary type.
我们之前报道了针对人甲状腺球蛋白(h-tg)的单克隆抗体(MAb)的制备及特性。在本研究中,对H10 I MAb针对不同形式的tg以及各种人类甲状腺肿瘤的免疫反应性进行了评估。通过与三碘甲状腺原氨酸(T3)、甲状腺素(T4)和人γ球蛋白无交叉反应,验证了H10 I MAb的特异性。在硝酸纤维素膜上对h-tg进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)免疫印迹显示,与多克隆抗体(PAb)反应时有多个免疫反应条带,而与H10 I MAb完全无反应。使用斑点免疫结合技术证明,经SDS处理、二硫苏糖醇(DT)处理和热变性的tg与H10 I MAb无免疫反应性。然而,H10 I MAb能够与用诸如尿素和盐酸胍等变性剂处理的tg发生反应。所有处理形式的tg都能被PAb同等识别。与天然tg相比,氧化/还原tg对H10 I MAb的免疫反应性明显降低(60.0%)。看来H10 I MAb针对的是涉及巯基键的构象表位。免疫组织化学方面,使用免疫过氧化物酶染色,在正常甲状腺组织、滤泡性甲状腺组织、许特耳细胞癌组织和低分化甲状腺肿瘤组织中观察到PAb和MAb之间具有相当的免疫反应性。乳头状癌组织(甲状腺以及转移淋巴结)的切片与PAb呈现强烈免疫反应性。这些切片上的甲状腺球蛋白未被H10 I MAb识别。尽管如此,H10 I MAb能够在存在滤泡分化的地方检测到tg。H10 I MAb在乳头状癌中无免疫反应性强烈表明,这种肿瘤产生的tg在抗原性上与正常组织中的蛋白质不同。H10 I MAb与原发灶不明的转移淋巴结的反应性表明其在识别除乳头状型以外的分化型甲状腺癌的常见转移方面有用。